Skip to Content

Xeno Transplants Corp XENO Stock Quote

| Rating as of


Morningstar‘s Stock Analysis XENO

Currency in USD
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Key Statistics XENO

Company Profile XENO

Business Description

Xeno Transplants Corp is a bio-technology research and development company, which intends to develop therapeutic applications of organs and cells derived from genetically engineered pigs as a transplant alternative to limited human donor sources.

143 Gardner Road
Brookline, MA, 02445
T +1 617 566-5228
Industry Biotechnology
Most Recent Earnings Mar 31, 2008
Fiscal Year End Jun 30, 2012